Clinical trial Recruiting at 1 site Observational Ages 3 to 18

Biofeedback system to improve robotic gait training for children with cerebral palsy

Official title: AID2GAIT: Biofeedback Based System to Enhance Robotic Assisted Gait Training in Children With Cerebral Palsy

Run by G. d'Annunzio University · NCT06947889 · Data updated 2026-11-12

This study is testing a new biofeedback system during robotic gait training to see if it can help children with cerebral palsy improve their walking skills.

Quick facts

Study typeObservational
Ages3 Years to 18 Years
SexAll
Enrollment11 (estimated)
SponsorG. d'Annunzio University
Academic / other
Locations1 site (San Giovanni Rotondo, FG)
StatusRecruiting
StartedJuly 1, 2024
Main results expectedMarch 31, 2025
Study endsFebruary 28, 2026
Registry record updatedApril 27, 2025
Trial IDNCT06947889 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children aged 3 to 18 years with cerebral palsy who can express discomfort and understand simple instructions.

Probably not a fit

Patients with severe lower limb conditions, uncontrolled seizures, or other medical issues that interfere with training may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The AID2GAIT project focuses on enhancing robotic-assisted gait training (RAGT) for children with cerebral palsy by integrating a biofeedback system. This system utilizes non-invasive technologies to monitor physiological signals, including heart rate variability from smartwatches, facial temperature via infrared thermography, and brain activity through functional near-infrared spectroscopy (fNIRS). Over 12 sessions of RAGT using the Lokomat exoskeleton, data will be collected to assess the effectiveness of the training and the psychophysiological state of the participants. The goal is to improve motor skills and overall treatment outcomes through real-time data analysis and machine learning models.

Why it matters

Potential benefit: If successful, this approach could significantly enhance the rehabilitation outcomes for children with cerebral palsy undergoing gait training.

How similar studies have gone: While the integration of biofeedback in robotic gait training is a novel approach, similar studies have shown promise in enhancing rehabilitation outcomes.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Children with cerebral palsy aged 3 to 18 years who have a GMFCS level from I to V, with the ability to express discomfort or pain and understanding simple instructions

Exclusion Criteria:

* Medical problems that could interfere with training and restrictions on the use of the robotic device;
* severe lower limb conditions: muscle contractures, instability or subluxation of the hip;
* recent botulinum toxin A injections to the lower limbs;
* uncontrolled seizures;
* open skin disorders and vascular disorders of the lower limbs.
* Contraindications to gait rehabilitation treatment with Lokomat (e.g. weight \<10 kg, non-consolidated fractures, cognitive deficits limiting communication).
* Contractures of fixed joints that limit the range of motion of the orthoses
* Inability to properly adjust the harness and/or orthoses

Where it's running

  • Fondazione Centri di Riabilitazione Padre Pio Onlus - Gli Angeli di Padre Pio
    San Giovanni Rotondo, Fg, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.